interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Tedizolid Phosphate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Tedizolid Phosphate, and who makes it?

Tedizolid Phosphate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Tedizolid Phosphate2 dosage-form groups in the Orange Book
0generic makers listed
  1. Tedizolid Phosphate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Powder, Intravenous

Brand listed, no generic listed as marketed

Brand listed as marketed: Sivextro. No generic is listed as marketed.

2010201520202025203001brand 2014data datePatent 8420676 listed to expire 23 February 2028Patent 7816379 listed to expire 20 June 2028Patent 9624250 listed to expire 3 February 2030Patent 9988406 listed to expire 3 February 2030Patent 10442829 listed to expire 3 February 2030Patent 10065947 listed to expire 3 February 2030Patent 8426389 listed to expire 31 December 2030Exclusivity NPP to 4 April 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 4 April 2028Exclusivity NPP Sivextro
  • 23 February 2028Patent 8420676 drug substance
  • 20 June 2028Patent 7816379 drug substance
  • 3 February 2030Patent 9624250 drug substance
  • 3 February 2030Patent 9988406 drug product
  • 3 February 2030Patent 10442829 drug substance
  • 3 February 2030Patent 10065947 drug product
  • 31 December 2030Patent 8426389 drug substance

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Sivextro. No generic is listed as marketed.

2010201520202025203001brand 2014data datePatent 8420676 listed to expire 23 February 2028Patent 7816379 listed to expire 20 June 2028Patent 9624250 listed to expire 3 February 2030Patent 9988406 listed to expire 3 February 2030Patent 10442829 listed to expire 3 February 2030Patent 10065947 listed to expire 3 February 2030Patent 8426389 listed to expire 31 December 2030Exclusivity NPP to 4 April 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 4 April 2028Exclusivity NPP Sivextro
  • 23 February 2028Patent 8420676 drug substance
  • 20 June 2028Patent 7816379 drug substance
  • 3 February 2030Patent 9624250 drug substance
  • 3 February 2030Patent 9988406 drug product
  • 3 February 2030Patent 10442829 drug substance
  • 3 February 2030Patent 10065947 drug product
  • 31 December 2030Patent 8426389 drug substance

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.